Market closed

Bioage Labs Inc/$BIOA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Bioage Labs Inc

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Ticker

$BIOA
Trading on

Industry

Pharmaceuticals

Employees

63

Bioage Labs Inc Metrics

BasicAdvanced
$122M
-
-$6.63
-
-
$122M
$4.68
$3.34
12.857
12.758
0.774
2.694
-33.04%
-25.44%
-50.35%
0.38
0.38
-0.703
-82.63%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BIOA

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Bioage Labs Inc stock?

Bioage Labs Inc (BIOA) has a market cap of $122M as of April 05, 2025.

What is the P/E ratio for Bioage Labs Inc stock?

The price to earnings (P/E) ratio for Bioage Labs Inc (BIOA) stock is 0 as of April 05, 2025.

Does Bioage Labs Inc stock pay dividends?

No, Bioage Labs Inc (BIOA) stock does not pay dividends to its shareholders as of April 05, 2025.

When is the next Bioage Labs Inc dividend payment date?

Bioage Labs Inc (BIOA) stock does not pay dividends to its shareholders.

What is the beta indicator for Bioage Labs Inc?

Bioage Labs Inc (BIOA) does not currently have a Beta indicator.